Concepedia

Gabrielle Chappell

GC

Statistics

Publications

6

Citations

270

H-Index

6

Active since

2002

Affiliations

Mayo Clinic in Arizona(Current)

Humanigen (United States)

Mayo Clinic in Florida

WinnMed

Mayo Clinic

Gabrielle Chappell is an author at Mayo Clinic in Arizona specializing in severe pneumonia management, pneumonia pharmacotherapy, and infectious diseases.

Publications per year

2002–2022

6

Publications

6

GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia

Zelalem Temesgen, Mariam Assi, Fnu Shweta et al. · Mayo Clinic Proceedings · 2020 · 88 citations · Full text

, , +7

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

Zelalem Temesgen, Charles D. Burger, Jason Baker et al. · The Lancet Respiratory Medicine · 2021 · 74 citations · Full text

, , +13

Is the radiation of chest pain a useful indicator of myocardial infarction? a prospective study of 541 patients

John Albarran, Beatrice C. Durham, J. I. Gowers et al. · Accident and Emergency Nursing · 2002 · 36 citations · Full text

, , +14

LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

Zelalem Temesgen, Charles D. Burger, Jason V. Baker et al. · medRxiv · 2021 · 34 citations · Full text

, , +17

First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe and Critical COVID-19 Pneumonia

Zelalem Temesgen, Mariam Assi, Paschalis Vergidis et al. · medRxiv · 2020 · 27 citations · Full text

, , +10

1–5 of 6